Font Size

SCREEN

Profile

Direction

Menu Style

Teaching Resources

The PowerPoint presentations and photographs provided below can be downloaded and used for personal and educational use.  We respectfully request that you do not alter the content, and acknowledge isirv-AVG when you use these resources. 

If you have any queries regarding appropriate use, please contact us.

 

Influenza Antivirals: Challenges and Future Directions – Professor Fred Hayden adobe pdf icon2

This presentation was given at the Health Protection Agency Pandemic Influenza Conference, June 2010.  It includes observations on the use of neuraminidase inhibitors during the 2009 influenza A(H1N1) pandemic, and details of investigational studies underway and future prospects for influenza antiviral agents.

Establishing surveillance for Neuraminidase Inhibitor Resistance - Professor Maria Zambon powerpoint icon2

This presentation was given at a ViRgil training course in October 2006.  It describes the points to consider when establishing a surveillance system for NI resistance, including choice of assay and analysis and interpretation of data.

Comparison of Neuraminidase Inhibition Assay Methodology - Professor Maria Zambon powerpoint icon2

This slide was presented at a ViRgil training course in October 2006.  It provides a simple comparison of the chemiluminescent and fluorometric assay methodology.

Micro-plaque assay of influenza virus sensitivity to NAI – Dr Mikhail Matrosovich adobe pdf icon2

This presentation was given at a ViRgil training course in October 2006.  It describes the plaque reduction assay methodology and provides guidance on interpretation of results.

Amantadine Resistance – Dr Alan Hay powerpoint icon2

This presentation was given at a ViRgil training course in October 2006.  It describes the mechanism of action of amantadine and the emergence and characterisation of amantadine resistant influenza viruses.

 
Mechanisms of Resistance – Dr Bruno Lina adobe pdf icon2

This presentation was given at a ViRgil training course in October 2006.  It describes the commonly occurring resistance mutants, including data on transmissibility.  It also provides an overview on the epidemiology and surveillance of resistance.

 

The Antiviral Activity of Oseltamivir against H5N1 Human A/Vietnam/1203/04 and A/Turkey/15/06 Influenza Viruses in Ferrets – Dr Elena Govorkova powerpoint icon2

This presentation was given at the ‘Options for the Control of Influenza’ conference in Toronto, 2007.  It describes the replication of two strains of the influenza A H5N1 virus in the respiratory tract and internal organs of ferrets and the efficacy of oseltamivir treatment.

Surface Structure of Neuraminidase Heads powerpoint icon2

This graphical representation was provided by Dr Jennifer McKimm-Breschkin of the Commonwealth Scientific and Industrial Research Organisation (CSIRO).  

It shows the structure of the tetramer NA ‘heads’, showing the 4-corners and the central ‘hole’, which can be seen in the electronmicrographs below.

Photographs gif-icon2

Electron-micrographs of 2-dimensional arrays of neuraminidase ‘heads’ (kindly provided by Dr Jennifer McKimm-Breschkin of CSIRO)
 

nabp101     nabp110     nabp125     nabp128     nabp133     nabp136


top of page